A Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in Patients With Dry Eye in the Controlled Adverse Environmental (CAE) Model



Status:Completed
Conditions:Ocular
Therapuetic Areas:Ophthalmology
Healthy:No
Age Range:18 - Any
Updated:10/14/2017
Start Date:April 2009
End Date:October 2009

Use our guide to learn which trials are right for you!

A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled, Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in Patients With Dry Eye in the Controlled Adverse Environmental (CAE) Model

The purpose of this study is to determine the safety and efficacy of an ocular sirolimus
(rapamycin) formulation compared to Placebo on the signs and symptoms of dry eye in the CAE
Model.


Inclusion Criteria include, but are not limited to:

- Have a reported history of dry eye in both eyes;

- Have a history of use of or desire to use an eye drop for dry eye symptoms within the
past 6 months.

Exclusion Criteria include, but are not limited to:

- Have contraindications to the use of the study medications;

- Have known allergy or sensitivity to the use of the study medications or diagnostic
dyes;
We found this trial at
1
site
138 Haverhill Street
Andover, Massachusetts 01810
?
mi
from
Andover, MA
Click here to add this to my saved trials